62 related articles for article (PubMed ID: 6127291)
21. [Effects of guanfacine on pre- and postsynaptic alpha-adrenoceptors studied in comparison with those of clonidine].
Nakagawa Y; Chin W; Imai S
Nihon Yakurigaku Zasshi; 1982 May; 79(5):431-9. PubMed ID: 6127290
[TBL] [Abstract][Full Text] [Related]
22. Hypotensive and hypertensive effects of catecholamines intrathecally injected in anesthetized rats.
del Carmen García M; Enero MA; Celuch SM
J Auton Nerv Syst; 1996 Jun; 59(1-2):17-26. PubMed ID: 8816361
[TBL] [Abstract][Full Text] [Related]
23. Effect of clonidine at steady state on blood pressure in spontaneously hypertensive rats. Interaction of various alpha-adrenoceptor antagonists.
Frisk-Holmberg M
Acta Physiol Scand; 1984 Jan; 120(1):37-42. PubMed ID: 6144238
[TBL] [Abstract][Full Text] [Related]
24. [Alpha-adrenoceptor blocking action of terazosin].
Hanazuka M; Horii D; Mizogami S
Nihon Yakurigaku Zasshi; 1986 Dec; 88(6):433-41. PubMed ID: 2881853
[TBL] [Abstract][Full Text] [Related]
25. [Antihypertensive effect of naftopidil (KT-611), a novel alpha 1-adrenoceptor antagonist, in freely moving experimental hypertensive rats and dogs].
Kawasaki H; Nakamura S; Takasaki K; Iwamoto T; Ohjimi H; Kushiku K; Furukawa T
Nihon Yakurigaku Zasshi; 1990 Sep; 96(3):129-39. PubMed ID: 1980256
[TBL] [Abstract][Full Text] [Related]
26. Relative contribution of alpha 1-adrenoceptor blocking activity to the hypotensive effect of the novel calcium antagonist monatepil.
Sugimoto T; Hosoki K; Karasawa T
J Cardiovasc Pharmacol; 1995 Jul; 26(1):55-60. PubMed ID: 7564365
[TBL] [Abstract][Full Text] [Related]
27. [Pharmacological analysis of the mode of action of mandelamidine with sustained antihypertensive effect. (II). Mechanism of transient hypotensive action of mandelamidine].
Ozawa H; Hironaka Y
Nihon Yakurigaku Zasshi; 1975 Sep; 71(6):559-71. PubMed ID: 1238327
[TBL] [Abstract][Full Text] [Related]
28. Calcium entry blocking, beta 1-adrenoceptor blocking and hypotensive effects of YM-16151-4.
Shibasaki K; Uchida W; Matsuda Y; Asano M
Arch Int Pharmacodyn Ther; 1991; 313():140-50. PubMed ID: 1687772
[TBL] [Abstract][Full Text] [Related]
29. The cardiovascular effects of trimazosin.
Constantine JW; Hess HJ
Eur J Pharmacol; 1981 Sep; 74(2-3):227-38. PubMed ID: 6120084
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular effects of a novel antihypertensive agent, SGB-1534, in miniature pigs.
Sakai K; Kuromaru O; Akima M; Yoshizawa M
Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):119-25. PubMed ID: 4062428
[TBL] [Abstract][Full Text] [Related]
31. Pharmacologic profile of urapidil.
van Zwieten PA
Am J Cardiol; 1989 Aug; 64(7):1D-6D. PubMed ID: 2569262
[TBL] [Abstract][Full Text] [Related]
32. Effects of a new antihypertensive agent, SGB-1534, on rat platelet aggregation.
Aono J; Sakai K
Jpn J Pharmacol; 1986 Dec; 42(4):493-500. PubMed ID: 2879951
[TBL] [Abstract][Full Text] [Related]
33. Mechanism(s) of the hypotensive effect of synthetic 1-O-octadecyl-2-O-acetyl-glycero-3-phosphorylcholine.
Kamitani T; Katamoto M; Tatsumi M; Katsuta K; Ono T; Kikuchi H; Kumada S
Eur J Pharmacol; 1984 Mar; 98(3-4):357-66. PubMed ID: 6144557
[TBL] [Abstract][Full Text] [Related]
34. Hypotensive effect in dogs and rats of intravenous injections of the alpha 1-adrenoreceptor antagonist benoxathian.
Massi M; Venturi F; Brasili L; Melchiorre C
Pharmacol Res Commun; 1986 Sep; 18(9):813-29. PubMed ID: 2879293
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological activities of the antihypertensive drug urapidil in the rat.
Verberne AJ; Rand MJ
Clin Exp Pharmacol Physiol; 1984; 11(4):407-11. PubMed ID: 6097380
[TBL] [Abstract][Full Text] [Related]
36. Antiarrhythmic, hypotensive and α1-adrenolytic properties of new 2-methoxyphenylpiperazine derivatives of xanthone.
Rapacz A; Pytka K; Sapa J; Kubacka M; Filipek B; Szkaradek N; Marona H
Eur J Pharmacol; 2014 Jul; 735():10-6. PubMed ID: 24751714
[TBL] [Abstract][Full Text] [Related]
37. Studies on the hypotensive mechanisms of NZ-105, a new dihydropyridine derivative, in rats and rabbits.
Shudo C; Masuda Y; Sakai T; Tanaka S; Shigenobu K; Kasuya Y
Gen Pharmacol; 1993 Mar; 24(2):411-8. PubMed ID: 8482525
[TBL] [Abstract][Full Text] [Related]
38. [Cardiovascular effect of a novel substance, 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl] ethyl]-2,4 (1H, 3H)-quinazolinedione monohydrochloride (SGB 1534)].
Uchida Y; Sugimoto T
Nihon Yakurigaku Zasshi; 1985 Jun; 85(6):447-51. PubMed ID: 2863201
[TBL] [Abstract][Full Text] [Related]
39. Vinigrol, a novel antihypertensive and platelet aggregation inhibitory agent produced by a fungus, Virgaria nigra. II. Pharmacological characteristics.
Ando T; Yoshida K; Okuhara M
J Antibiot (Tokyo); 1988 Jan; 41(1):31-5. PubMed ID: 2831182
[TBL] [Abstract][Full Text] [Related]
40. Antihypertensive and Hypolipidemic Effects of DC-015, a Novel, Potent and Specific alpha(1)-Adrenoceptor Antagonist: Comparison with Prazosin in Spontaneously Hypertensive Rats.
Peng IH; Sheu JR; Chern JW; Lee YM; Yen MH
J Biomed Sci; 1996 Apr; 3(2):108-116. PubMed ID: 11725091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
